Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons
Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups. The objective of this survey was to assess the level of influenza vaccination coverage during two consecutive influenza seas...
Gespeichert in:
Veröffentlicht in: | Vaccine 2005-10, Vol.23 (43), p.5055-5063 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5063 |
---|---|
container_issue | 43 |
container_start_page | 5055 |
container_title | Vaccine |
container_volume | 23 |
creator | Szucs, Thomas D. Müller, Daniela |
description | Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups.
The objective of this survey was to assess the level of influenza vaccination coverage during two consecutive influenza seasons (2002/2003 and 2003/2004) in six European countries, to understand the driving forces and barriers to vaccination and to determine vaccination intentions for the following winter.
We conducted a random-sampling, telephone-based household survey among non-institutionalised individuals representative of the population aged 14 and over. The surveys used the same questionnaire for two consecutive winters: 2002/2003 and 2003/2004 data were used for Germany, Italy, Spain and the United Kingdom. 2001/2002 and 2002/2003 data were used for France. The data were subsequently pooled. Four target groups were determined for analysis: (1) persons aged 65 and over; (2) people working in the medical field; (3) persons suffering from chronic illness and (4) a group composed of persons aged 65 and over or working in the medical field or suffering from a chronic illness.
The overall sample consisted of 20,118 individuals. The influenza vaccination coverage rate increased from 21.3% in the first season to 23.2% in the second season. The increase in coverage is statistically significant (
p
=
0.01). The most frequent reasons for being vaccinated given by vaccines were: influenza, considered to be a serious illness which people wanted to avoid (55.8%), having received advice from the family doctor or nurse to be vaccinated (55.2%) and not wanting to infect family and friends (36.1%). Reasons for not being vaccinated mentioned by people who have never been vaccinated were: not expecting to catch influenza (40.4%), not having considered vaccination before (33.3%) and not having received a recommendation from the family doctor to be vaccinated (27.3%). Options encouraging influenza vaccination are: recommendation by the family doctor or nurse (53.1%), more available information on the vaccine regarding efficacy and tolerance (32.1%) and more information available about the disease (26.7%). Adjusted odds ratios for target group vaccination were between 3.6 (Germany) and 13.7 (UK). Vaccination rates among healthcare workers were generally very low. Adjusted odds ratios were between 0.7 (Germany) and 1.5 (Spain).
The vaccination coverage during the second season increased in comparison |
doi_str_mv | 10.1016/j.vaccine.2005.06.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68606939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X05005876</els_id><sourcerecordid>17483213</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-71b959833982d2ce96d536083739a681afe278650215373b0cbd6a104f27b1e33</originalsourceid><addsrcrecordid>eNqFkc-KFDEQxoMo7jj6CEpA9NZt_nTS3SeRZdWFBS8K3kJ1uloy9CRj0j3LevIZxCf0SUzvNC542UsKqn718aU-Qp5zVnLG9ZtdeQRrncdSMKZKpstcHpANb2pZCMWbh2TDhK6KirOvZ-RJSjuWCcnbx-SMa1ZpJtWG_Lr0wzij_wH0pAeTC57acMQI35BGmDBR5-ngjkgv5hgOCMt89lN0mP78_A30EA7zeLtYdJCwpzaGlIqEdunBSCE_N8klGgY6XYe87vNwnhZN989AQkh58JQ8GmBM-GytW_Ll_cXn84_F1acPl-fvrgpbKTEVNe9a1TZSto3ohcVW90pq1shatqAbDgOKutGKCa5yr2O26zVwVg2i7jhKuSWvT7qHGL7PmCazd8niOILHMCejG810K9t7QV5XjRR8UXz5H7gLc8x_z4xSTTbbCpEpdaJurxRxMIfo9hBvDGdmydbszJqtWbI1TJsluS15sarP3R77u601zAy8WgFIFsYhgrcu3XE1F1qJxebbE4f5ukeH0STr0FvsXcyRmT64e6z8Bfq6x7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1558983922</pqid></control><display><type>article</type><title>Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Szucs, Thomas D. ; Müller, Daniela</creator><creatorcontrib>Szucs, Thomas D. ; Müller, Daniela</creatorcontrib><description>Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups.
The objective of this survey was to assess the level of influenza vaccination coverage during two consecutive influenza seasons (2002/2003 and 2003/2004) in six European countries, to understand the driving forces and barriers to vaccination and to determine vaccination intentions for the following winter.
We conducted a random-sampling, telephone-based household survey among non-institutionalised individuals representative of the population aged 14 and over. The surveys used the same questionnaire for two consecutive winters: 2002/2003 and 2003/2004 data were used for Germany, Italy, Spain and the United Kingdom. 2001/2002 and 2002/2003 data were used for France. The data were subsequently pooled. Four target groups were determined for analysis: (1) persons aged 65 and over; (2) people working in the medical field; (3) persons suffering from chronic illness and (4) a group composed of persons aged 65 and over or working in the medical field or suffering from a chronic illness.
The overall sample consisted of 20,118 individuals. The influenza vaccination coverage rate increased from 21.3% in the first season to 23.2% in the second season. The increase in coverage is statistically significant (
p
=
0.01). The most frequent reasons for being vaccinated given by vaccines were: influenza, considered to be a serious illness which people wanted to avoid (55.8%), having received advice from the family doctor or nurse to be vaccinated (55.2%) and not wanting to infect family and friends (36.1%). Reasons for not being vaccinated mentioned by people who have never been vaccinated were: not expecting to catch influenza (40.4%), not having considered vaccination before (33.3%) and not having received a recommendation from the family doctor to be vaccinated (27.3%). Options encouraging influenza vaccination are: recommendation by the family doctor or nurse (53.1%), more available information on the vaccine regarding efficacy and tolerance (32.1%) and more information available about the disease (26.7%). Adjusted odds ratios for target group vaccination were between 3.6 (Germany) and 13.7 (UK). Vaccination rates among healthcare workers were generally very low. Adjusted odds ratios were between 0.7 (Germany) and 1.5 (Spain).
The vaccination coverage during the second season increased in comparison to the first season. The family doctor is the most important source of encouragement for people to be vaccinated against influenza. It seems that the public would be more likely to be vaccinated if they had more information on the efficacy and tolerance of the vaccine, as well as the disease. We, therefore, suggest that family doctors be better informed on influenza vaccine and the disease itself, so that they can actively inform their patients on these topics.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2005.06.005</identifier><identifier>PMID: 16046035</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Applied microbiology ; Biological and medical sciences ; Chronic illnesses ; Coverage ; Cross-Sectional Studies ; Elderly ; Europe ; Europe - epidemiology ; Fundamental and applied biological sciences. Psychology ; Health care ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility - statistics & numerical data ; Health Surveys ; Humans ; Immunization ; Influenza ; Influenza Vaccines - administration & dosage ; Influenza virus ; Influenza, Human - epidemiology ; Influenza, Human - prevention & control ; Medical personnel ; Microbiology ; Middle Aged ; Patient Compliance - statistics & numerical data ; Seasons ; Target groups ; Vaccination ; Vaccination - statistics & numerical data ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><ispartof>Vaccine, 2005-10, Vol.23 (43), p.5055-5063</ispartof><rights>2005 Elsevier Ltd</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Elsevier Limited Oct 17, 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-71b959833982d2ce96d536083739a681afe278650215373b0cbd6a104f27b1e33</citedby><cites>FETCH-LOGICAL-c452t-71b959833982d2ce96d536083739a681afe278650215373b0cbd6a104f27b1e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X05005876$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17126523$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16046035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szucs, Thomas D.</creatorcontrib><creatorcontrib>Müller, Daniela</creatorcontrib><title>Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups.
The objective of this survey was to assess the level of influenza vaccination coverage during two consecutive influenza seasons (2002/2003 and 2003/2004) in six European countries, to understand the driving forces and barriers to vaccination and to determine vaccination intentions for the following winter.
We conducted a random-sampling, telephone-based household survey among non-institutionalised individuals representative of the population aged 14 and over. The surveys used the same questionnaire for two consecutive winters: 2002/2003 and 2003/2004 data were used for Germany, Italy, Spain and the United Kingdom. 2001/2002 and 2002/2003 data were used for France. The data were subsequently pooled. Four target groups were determined for analysis: (1) persons aged 65 and over; (2) people working in the medical field; (3) persons suffering from chronic illness and (4) a group composed of persons aged 65 and over or working in the medical field or suffering from a chronic illness.
The overall sample consisted of 20,118 individuals. The influenza vaccination coverage rate increased from 21.3% in the first season to 23.2% in the second season. The increase in coverage is statistically significant (
p
=
0.01). The most frequent reasons for being vaccinated given by vaccines were: influenza, considered to be a serious illness which people wanted to avoid (55.8%), having received advice from the family doctor or nurse to be vaccinated (55.2%) and not wanting to infect family and friends (36.1%). Reasons for not being vaccinated mentioned by people who have never been vaccinated were: not expecting to catch influenza (40.4%), not having considered vaccination before (33.3%) and not having received a recommendation from the family doctor to be vaccinated (27.3%). Options encouraging influenza vaccination are: recommendation by the family doctor or nurse (53.1%), more available information on the vaccine regarding efficacy and tolerance (32.1%) and more information available about the disease (26.7%). Adjusted odds ratios for target group vaccination were between 3.6 (Germany) and 13.7 (UK). Vaccination rates among healthcare workers were generally very low. Adjusted odds ratios were between 0.7 (Germany) and 1.5 (Spain).
The vaccination coverage during the second season increased in comparison to the first season. The family doctor is the most important source of encouragement for people to be vaccinated against influenza. It seems that the public would be more likely to be vaccinated if they had more information on the efficacy and tolerance of the vaccine, as well as the disease. We, therefore, suggest that family doctors be better informed on influenza vaccine and the disease itself, so that they can actively inform their patients on these topics.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Chronic illnesses</subject><subject>Coverage</subject><subject>Cross-Sectional Studies</subject><subject>Elderly</subject><subject>Europe</subject><subject>Europe - epidemiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Health care</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Health Services Accessibility - statistics & numerical data</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Immunization</subject><subject>Influenza</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Influenza virus</subject><subject>Influenza, Human - epidemiology</subject><subject>Influenza, Human - prevention & control</subject><subject>Medical personnel</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Patient Compliance - statistics & numerical data</subject><subject>Seasons</subject><subject>Target groups</subject><subject>Vaccination</subject><subject>Vaccination - statistics & numerical data</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc-KFDEQxoMo7jj6CEpA9NZt_nTS3SeRZdWFBS8K3kJ1uloy9CRj0j3LevIZxCf0SUzvNC542UsKqn718aU-Qp5zVnLG9ZtdeQRrncdSMKZKpstcHpANb2pZCMWbh2TDhK6KirOvZ-RJSjuWCcnbx-SMa1ZpJtWG_Lr0wzij_wH0pAeTC57acMQI35BGmDBR5-ngjkgv5hgOCMt89lN0mP78_A30EA7zeLtYdJCwpzaGlIqEdunBSCE_N8klGgY6XYe87vNwnhZN989AQkh58JQ8GmBM-GytW_Ll_cXn84_F1acPl-fvrgpbKTEVNe9a1TZSto3ohcVW90pq1shatqAbDgOKutGKCa5yr2O26zVwVg2i7jhKuSWvT7qHGL7PmCazd8niOILHMCejG810K9t7QV5XjRR8UXz5H7gLc8x_z4xSTTbbCpEpdaJurxRxMIfo9hBvDGdmydbszJqtWbI1TJsluS15sarP3R77u601zAy8WgFIFsYhgrcu3XE1F1qJxebbE4f5ukeH0STr0FvsXcyRmT64e6z8Bfq6x7A</recordid><startdate>20051017</startdate><enddate>20051017</enddate><creator>Szucs, Thomas D.</creator><creator>Müller, Daniela</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20051017</creationdate><title>Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons</title><author>Szucs, Thomas D. ; Müller, Daniela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-71b959833982d2ce96d536083739a681afe278650215373b0cbd6a104f27b1e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Chronic illnesses</topic><topic>Coverage</topic><topic>Cross-Sectional Studies</topic><topic>Elderly</topic><topic>Europe</topic><topic>Europe - epidemiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Health care</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Health Services Accessibility - statistics & numerical data</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Immunization</topic><topic>Influenza</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Influenza virus</topic><topic>Influenza, Human - epidemiology</topic><topic>Influenza, Human - prevention & control</topic><topic>Medical personnel</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Patient Compliance - statistics & numerical data</topic><topic>Seasons</topic><topic>Target groups</topic><topic>Vaccination</topic><topic>Vaccination - statistics & numerical data</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szucs, Thomas D.</creatorcontrib><creatorcontrib>Müller, Daniela</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szucs, Thomas D.</au><au>Müller, Daniela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2005-10-17</date><risdate>2005</risdate><volume>23</volume><issue>43</issue><spage>5055</spage><epage>5063</epage><pages>5055-5063</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Influenza continues to be a considerable health problem in Europe. Vaccination is the only preventive measure, reducing mortality and morbidity of influenza in all age groups.
The objective of this survey was to assess the level of influenza vaccination coverage during two consecutive influenza seasons (2002/2003 and 2003/2004) in six European countries, to understand the driving forces and barriers to vaccination and to determine vaccination intentions for the following winter.
We conducted a random-sampling, telephone-based household survey among non-institutionalised individuals representative of the population aged 14 and over. The surveys used the same questionnaire for two consecutive winters: 2002/2003 and 2003/2004 data were used for Germany, Italy, Spain and the United Kingdom. 2001/2002 and 2002/2003 data were used for France. The data were subsequently pooled. Four target groups were determined for analysis: (1) persons aged 65 and over; (2) people working in the medical field; (3) persons suffering from chronic illness and (4) a group composed of persons aged 65 and over or working in the medical field or suffering from a chronic illness.
The overall sample consisted of 20,118 individuals. The influenza vaccination coverage rate increased from 21.3% in the first season to 23.2% in the second season. The increase in coverage is statistically significant (
p
=
0.01). The most frequent reasons for being vaccinated given by vaccines were: influenza, considered to be a serious illness which people wanted to avoid (55.8%), having received advice from the family doctor or nurse to be vaccinated (55.2%) and not wanting to infect family and friends (36.1%). Reasons for not being vaccinated mentioned by people who have never been vaccinated were: not expecting to catch influenza (40.4%), not having considered vaccination before (33.3%) and not having received a recommendation from the family doctor to be vaccinated (27.3%). Options encouraging influenza vaccination are: recommendation by the family doctor or nurse (53.1%), more available information on the vaccine regarding efficacy and tolerance (32.1%) and more information available about the disease (26.7%). Adjusted odds ratios for target group vaccination were between 3.6 (Germany) and 13.7 (UK). Vaccination rates among healthcare workers were generally very low. Adjusted odds ratios were between 0.7 (Germany) and 1.5 (Spain).
The vaccination coverage during the second season increased in comparison to the first season. The family doctor is the most important source of encouragement for people to be vaccinated against influenza. It seems that the public would be more likely to be vaccinated if they had more information on the efficacy and tolerance of the vaccine, as well as the disease. We, therefore, suggest that family doctors be better informed on influenza vaccine and the disease itself, so that they can actively inform their patients on these topics.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>16046035</pmid><doi>10.1016/j.vaccine.2005.06.005</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2005-10, Vol.23 (43), p.5055-5063 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_68606939 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Aged Applied microbiology Biological and medical sciences Chronic illnesses Coverage Cross-Sectional Studies Elderly Europe Europe - epidemiology Fundamental and applied biological sciences. Psychology Health care Health Knowledge, Attitudes, Practice Health Services Accessibility - statistics & numerical data Health Surveys Humans Immunization Influenza Influenza Vaccines - administration & dosage Influenza virus Influenza, Human - epidemiology Influenza, Human - prevention & control Medical personnel Microbiology Middle Aged Patient Compliance - statistics & numerical data Seasons Target groups Vaccination Vaccination - statistics & numerical data Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) |
title | Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T08%3A38%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influenza%20vaccination%20coverage%20rates%20in%20five%20European%20countries%E2%80%94a%20population-based%20cross-sectional%20analysis%20of%20two%20consecutive%20influenza%20seasons&rft.jtitle=Vaccine&rft.au=Szucs,%20Thomas%20D.&rft.date=2005-10-17&rft.volume=23&rft.issue=43&rft.spage=5055&rft.epage=5063&rft.pages=5055-5063&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2005.06.005&rft_dat=%3Cproquest_cross%3E17483213%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1558983922&rft_id=info:pmid/16046035&rft_els_id=S0264410X05005876&rfr_iscdi=true |